雷公藤醇
纳米载体
类风湿性关节炎
脂质体
靶向给药
药物输送
炎症
药理学
药品
关节炎
医学
毒品携带者
靶向治疗
炎性关节炎
促炎细胞因子
治疗效果
输送系统
趋化性
癌症研究
化学
免疫学
消炎药
作者
Yunshuang Jiao,Jicong Chen,Huijia Lei,Siyuan Hu,Yuanhao Yu,Jinsheng Yang,Yuyang Chen,Jie Yang,Lesheng Teng
出处
期刊:Nano Letters
[American Chemical Society]
日期:2026-02-16
卷期号:26 (7): 2381-2388
被引量:3
标识
DOI:10.1021/acs.nanolett.5c05149
摘要
Rheumatoid arthritis (RA) may lead to irreversible joint damage, seriously affecting the health of patients. Cell-mediated drug delivery strategies provide a significant promise for improving drug delivery efficiency and enhancing therapeutic efficacy in RA. Herein, a neutrophil-mediated nanoplatform, constructed from celastrol-loaded liposome (LP-Cel) and neutrophils (NEs) on the outer surface capable of inflammation migration ability, namely, NEs-LP-Cel, is developed for RA treatment. By exploiting the inflammatory environment of RA and the inflammatory chemotaxis of neutrophils, LP-Cel is transported to inflamed tissues to release celastrol and display anti-inflammatory effects. Experimental results demonstrate that NEs-LP-Cel can effectively accumulate at the inflammation sites, reduce paw swelling, and decrease the expression of inflammatory factors (TNF-α and IL-1β) in joint tissues of RA rats, indicating enhanced therapeutic effects and negligible side effects, providing a new way for using neutrophil-mediated nanocarriers as delivery nanoplatforms to achieve treatment in inflammatory diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI